Oral leukoplakia: Clinical, histopathologic, and molecular features and therapeutic approach;La leucoplasia oral: Definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica

Actas Dermo-Sifiliograficas

Volumn 100, Issue 8, 2009, Pages 669-684

  Martorell Calatayud, A ^a   Botella Estrada, R ^a   Bagan Sebastian J V ^b   Sanmartin Jimenez O ^a   Guillen Barona C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Leukoplakia; Risk of transformation; Therapy; Tobacco

Indexed keywords

BLEOMYCIN; CD147 ANTIGEN; CYCLOOXYGENASE 2; KERATIN; LYCOPENE; METALLOPROTEINASE; MICROSATELLITE DNA; PACLITAXEL; PROTEIN P53; RETINOID; TELOMERASE;

ANEUPLOIDY; CANDIDIASIS; CARBON DIOXIDE LASER; CIGARETTE SMOKING; CRYOSURGERY; DERMATITIS; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; KERATINIZATION; LEUKODERMA; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; MOUTH CANCER; PAPILLOMA VIRUS; PRECANCER; REVIEW; STOMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VERRUCA VULGARIS;

ALGORITHMS; HUMANS; LEUKOPLAKIA, ORAL;

EID: 70350755563     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(09)70149-0     Document Type: Article

References (90)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J Clin 50 2000 7 33
2. J. Paricio-Rubio, J. Revenga-Arranz, T. Ramírez-Gasca, and P. Boned-Blas Leucoqueratosis nicotínica del paladar Actas Dermosifiliogr 93 2002 38 41
3. S.K. Mithani, W.K. Mydlarz, F.L. Grumbine, I.M. Smith, and J.A. Califano Molecular genetics of premalignant oral lesions Oral Dis 13 2007 126 133
4. S.M. Lippman, and W.K. Hong Molecular markers of the risk of oral cancer N Engl J Med 344 2001 1323 1326
5. J.J. Pindborg, P. Reichart, C.J. Smith, and I. Van der Waal World Health Organization: histological typing of cancer and precancer of the oral mucosa 1997 Springer-Verlag Berlin
6. J. Sudbø, and A. Reith The evolution of predictive oncology and molecular-based therapy for oral cancer prevention Int J Cancer 115 2005 339 345 (Pubitemid 40663735)
7. J. Bánoczy, Z. Gintner, and C. Dombi Tobacco use and oral leucoplakia J Dental Educ 65 2001 322 327
8. J.E. Bouquot, L.H. Weiland, and L.T. Kurland Leucoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn, 1935-1984 Oral Surg Oral Med Oral Pathol Oral Radiol Endod 65 1998 199 207
9. K.K.H. Gundlach Wieviele plattenepthelkarzinome der mundhöhle sind aus leukoplakien enstanden? Dtch Z Mundokierfer-gesichts-Chir 16 1992 109 111
10. K. Schepman, E.H. van der Meij, L. Smeele, and I. van derl Waal Concomitant leucoplakia in patients with oral squamous cell carcinoma Oral Dis 5 1999 206 209
11. K.O. Duncan, J.K. Geisse, and D.J. Leffel Epidermal and appendageal tumors K. Wolff L.A. Goldsmith S.I. Katz B.A. Gilchrest A.S. Paller D.J. Leffell Fitzpatrick's Dermatology in general medicine 7th ed. 2007 McGraw Hill 1024 1026
12. J.J. Pindborg, J. Reibel, B. Roed-Petersn, and F.S. Mehta Tobaccoinduced changes in oral leukoplakic epithelium Cancer 45 1980 2330 2336
13. A. Jepsen, and J.E. Winther Mycotic infection in oral leukoplakia Acta Ondontol Scand 23 1965 239 256
14. G. Renstrup Occurrence of candida in oral leukoplakias Acta Pathol Microbiol Scand [B] Microbiol Immunol 78 1970 421 424
15. J. Reibel Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics Crit Rev Oral Biol Med 14 2003 47 62
16. H. Nielsen, B. Norrild, P. Vedtofte, F. Praetorius, J. Reibel, and P. Holmstrup Human papilomavirus in oral premalignant lesions Eur J Cancer B Oral Oncol 32 1996 264 270
17. F. Praetorius HPV-associated diseases of oral mucosa Clin Dermatol 15 1997 299 413
18. C.S. Miller, and B.M. Johnstone Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997 Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 2001 622 635
19. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, and W.M. Koch Casecontrol study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956 (Pubitemid 46740304)
20. J.V. Bagán, Y. Jiménez, J. Murillo, C. Gavaldá, R. Poveda, and C. Scully et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection J Oral Maxillofac Surg 65 2007 46 49
21. J.V. Bagán, Y. Jiménez, J. Murillo, R. Poveda, J.M. Díaz, and C. Gavaldá et al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study Med Oral Patol Oral Cir Bucal 13 2008 E110 E113
22. M.J. Renan How many mutations are required for tumorigenesis? Implications for human cancer data Mol Carcinog 7 1993 139 146
23. L. Zhang, and M.P. Rosin Loss of heterocigosity: a potencial tool in management of oral premalignant lesions? J Oral Pathol Med 30 2001 513 520
24. J. Sudbø, S.M. Lippman, J.J. Lee, L. Mao, W. Kildal, and A. Sudbø et al. The influence of resection and aneuploidy on mortality in oral leukoplakia N Engl J Med 350 2004 1405 1413
25. L. Zhang, C.F. Poh, W.L. Lam, J.B. Epstein, X. Cheng, and X. Zhang et al. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection Oral Oncol 37 2001 505 512
26. Curfman GD, Morrissey S, Drazen JM. Retraction of: «Sudbø J et al. et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med. 2001;344: 1270-8 and Sudbø J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13.» N Engl J Med. 2006;355:1927.
27. M.S. Greenblatt, W.P. Bennet, M. Hollstein, and C.C. Harris Mutations in the p53 tumor supressor gene:clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
28. S. Warnakulasuriya p53 and oral precancer - a review A.K. Warma Oral oncology 1998 Mc Millan New Delhi 93 96
29. I.B. Cruz, P.J. Snijders, C.J. Meijer, B.J. Braakhuis, G.B. Snow, and J.M. Walboomers et al. P53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma J Pathol 184 1998 360 368
30. L. Poeta, J. Manola, M.A. Goldwasser, A. Forastiere, N. Benoit, and J.A. Califano et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck N Engl J Med 357 2007 2552 2561
31. B. Luzar, M. Poljak, I.J. Marin, A. Eberlinc, U. Klopcic, and N. Gale Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis Histopathology 45 2004 13 19
32. V. Ravn, and E. Dabelsteen Tissue distribution of histo-blood group antigens APMIS 108 2000 1 28
33. E. Dabelsteen ABO blood group antigens in oral mucosa. What is new? J Oral Pathol Med 31 2002 65 70
34. A.G. Banerjee, I. Bhattacharyya, and J.K. Vishwanatha Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia Mol Cancer Ther 4 2005 865 875
35. E. Dabelsteen, B. Gron, U. Mandel, and I. Mackenzie Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds J Invest Dermatol 111 1998 592 597
36. P.R. Morgan, I.M. Leigh, P.E. Purkis, I.D. Gardner, G.N.P. van Muijen, and E.B. Lane Site variation of keratin expression in human oral epithelia-an immunocytochemical study on individual keratins Epithelia 1 1987 33 43
37. B.K. Bloor, S.V. Seddon, and P.R. Morga Gene expression of diferentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma Oral Oncol 37 2001 251 261
38. S. Hamidi, T. Salo, T. Kainulainen, J. Epstein, K. Lerner, and H. Larjava Expression of alpha(v)beta 6 integrin in oral leukoplakia Br J Cancer 82 2000 1433 1440
39. M.Y. Kuo, S.J. Cheng, H.M. Chen, S.H. Kok, L.J. Hahn, and C.P. Chiang Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan J Oral Pathol Med 27 1998 428 433
40. H. Sunaga, S. Fujieda, H. Tsuzuki, K. Asamoto, M. Fukuda, and H. Saito Expression of granulocyte colony stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions Anticancer Res 21 2001 2901 2906
41. M. Sirinivasan, and S.D. Jewell Evaluation of TGF-and EFGR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry Oral Oncol 61 2001 284 292
42. S. Soni, J. Kaur, A. Kumar, N. Chakravarti, M. Mathur, and S. Bahadur et al. Alterations of Rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma Oncology 68 2005 314 325
43. J.G. Izzo, V.A. Papadimitrakopoulou, X.Q. Li, H. Ibarquen, J.S. Lee, and J.Y. Ro et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification Oncogene 17 1998 2313 2322
44. R.C. Jordan, M. Macabeo-Ong, C.H. Shiboski, N. Dekker, D.G. Ginzinger, and D.T. Wong et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer Clin Cancer Res 10 2004 6460 6465
45. N. Vigneswaran, S. Beckers, S. Waigel, J. Mensah, J. Wu, and J. Mo et al. Increased EMMPRIN (CD147) expression during oral carcinogenesis Exp Mol Pathol 80 2006 147 159
46. S. Arora, J. Kaur, C. Sharma, M. Mathur, S. Bahadur, and N.K. Shukla et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression and prognosis Clin Cancer Res 11 2005 2272 2284
47. T. Axéll, J.J. Pindborg, C.J. Smith, and I. van der Waal Oral white lesions with special reference to precancerous and tobaccorelated lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions J Oral Pathol Med 25 1996 49 54
48. S Silverman Jr, M. Gorsky, and F. Lozada Oral leukoplakia and malignant transformation. A follow up study of 257 patients Cancer 53 1984 563 568
49. P.O. Lind Malignant transformation in oral leucoplakia Scand J Dent Res 95 1987 449 455
50. P.C. Gupta, R.B. Bhonsle, P.R. Murti, D.K. Daftary, F.S. Mehta, and J.J. Pindborg An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia Cancer 63 1989 2247 2252
51. L.S. Hansen, J.A. Olson, and S.J. Silverman Proliferative verrucous leukoplakia. A long-term study of thirty patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 60 1985 285 298
52. S. Silverman Jr, and M. Gorsky Proliferative verrucous leukoplakia: a follow up study of 54 cases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 1968 154 157
53. P.J. Slootweg, and H. Müller Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients J Maxillofac Surg 11 1983 13 19
54. I.R. Kramer, N. el-Labban, and K.W. Lee The clinical features and risk of malignant transformation in sublingual keratosis Nr Dent J 144 1978 171 180
55. C.A. Lesh, C.A. Squier, A. Cruchley, D.M. Williams, and P. Speight The permeability of human oral mucosa and skin to water J Dent Res 68 1989 1345 1349
56. J.J. Sciubba Oral leukoplakia Crit Rev Oral Biol Med 6 1995 147 160
57. F.S. Mehta, J.J. Pindborg, P.C. Gupta, and D.K. Daftary Epidemiologic and histologic study of oral cancer and leucoplasia among 50,915 villagers in India Cancer 24 1996 832 849
58. J. Bánóczy, and A. Csiba Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 42 1976 766 774
59. C.A. Waldron, and W.G. Shafer Leucoplakia revisited. A clinicopathologic study 3256 oral leucoplakias Cancer 36 1975 1386 1392
60. S. Silverman, K. Bhargava, L.W. Smith, and A.M. Malaowalla Malignant transformation and natural history of oral leucoplakia in 57,518 workers on Gujarat, India Cancer 38 1976 563 568
61. S. Silverman Jr, M. Gorsky, and F. Lozada Leucoplakia, dysplasia and malignant transformation Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82 1996 117
62. K.P. Schepman, E.H. van der Meij, L.E. Smeele, and I. van del Waal Malignant transformation of oral leukoplakia: a follow up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands Oral Oncol 34 1998 270 275
63. D.J. Brothwell, D.W. Lewis, G. Bradley, I. Leong, R.C. Jordan, and D. Mock et al. Observer agreement in the grading of oral epithelial dysplasia Community Dent Oral Epidemiol 31 2003 300 305
64. H.H. Mincer, S.A. Coleman, and K.P. Hopkins Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 33 1972 389 399
65. J. Bánóczy Follow up studies in oral leukoplakia J Maxillofac Surg 5 1977 69 75
66. P.C. Gupta, F.S. Mehta, D.K. Daftary, J.J. Pindborg, R.B. Bhonsle, and P.N. Jalnawalla et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow up study of Indian villagers Community Dent Oral Epidemiol 6 1980 283 333
67. C.G. Cowan, T.A. Gregg, S.S. Napier, S.M. McKenna, and F. Kee Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation Oral Dis 7 2001 18 24
68. E. Natarajan, and S.B. Woo Benign alveolar ridge keratosis (oral lichen simplex chronicus): A distinct clinicopathologic entity J Am Acad Dermatol 58 2008 151 157
69. A.C. Chi, P.R. Lambert 3rd, Y. Pan, R. Li, D.T. Vo, and E. Edwards et al. Is alveolar ridge keratosis a true leukoplakia?: A clinicopathologic comparison of 2,153 lesions J Am Dent Assoc 138 2007 641 651
70. G. Lodi, A. Sardella, C. Bez, F. Demarosi, and A. Carrassi Interventions for treating oral leukoplakia Cochrane Database Syst Rev 2006
71. M. Brennan, C.A. Migliorati, P.B. Lockhart, D. Wray, I. Al-Hashimi, and T. Axéll et al. Management of oral epithelial dysplasia: a review Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl 2007 S19.e1 S19.e12
72. J.J. Lee, W.K. Hong, W.N. Hittelman, L. Mao, R. Lotan, and D.M. Shin et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development Clin Cancer Res 8 2002 314 346
73. J.S. Lee, V.M. Papadimitrakopoulou, C. Geyer, C. Perez, J.W. Martin, and A.K. El-Naggar et al. Predicting cancer development in oral leukoplakia: ten years of translational research Clin Cancer Res 6 2000 1702 1710
74. B.J. Braakhuis, M.P. Tabor, J.A. Kummer, C.R. Leemans, and R.H. Brakenhoff A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications Cancer Res 63 2003 1727 1730
75. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat Rev Cancer 2002 537 543
76. J. Sudbø, A. Ristimäki, J.E. Sondresen, W. Kildal, M. Boysen, and H.S. Koppang et al. Cyclooxigenasae-2 (COX-2) expression in high risk premalignant lessions Oral Oncol 39 2003 497 505
77. S. Han, and J. Roman Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligans inhibits human lung carcinoma cell growth Biochem Biophys Res Commun 314 2004 1093 1099
78. R.O. Pomerantz, and I.R. Grandis The role of epidermal growth factor receptor in head and neck squamous cell carcinoma Curr Oncol Rep 5 2003 140 146
79. L.D. Ke, K. Adler-Storthz, G.L. Clayman, A.W. Yung, and Z. Chen Differential expression of epidermal growth factor receptor in human head and neck cancers Head Neck 20 1998 320 327
80. I.R. Grandis, and D.I. Tweardy Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early maskers of carcinogenesis in head and neck cancer Cancer Res 53 1993 3579 3584
81. J. Rubin Grandis, D.J. Tweardy, and M.F. Melhern Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma Clin Cancer Res 4 1998 13 20
82. F.C. Holsinger, D.D. Doan, S.A. Jasser, E.A. Swan, J.S. Greenberg, and B.A. Schiff et al. Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads for prolonged survival in a murine model of oral cancer Clin Cancer Res 9 2003 3183 3189
83. C.I. Torrance, P.E. Jackson, E. Montgomery, K.W. Kinzler, B. Vogelstein, and A. Wissner et al. Combinatorial chemoprevention of intestinal neoplasia Nat Med 6 2000 1024 1028
84. T.I. Maier, K. Schilling, R. Schmidt, O. Geisslinger, and S. Grosch Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells Biochem Pharmacol 67 2004 1469 1478
85. E.M. Boon, J.I. Keller, T.A. Wormhoudt, F.M. Giardiello, G.J. Offerhaus, and R. van der Neut et al. Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines Br J Cancer 90 2004 224 229
86. C. Han, J. Leng, A.J. Demetris, and T. Wu Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest Cancer Res 64 2004 1369 1376
87. S.K. Kulp, Y.T. Yang, C.C. Hung, K.F. Chen, J.P. Lai, and P.H. Tseng et al. 3-phosphoinositide-dependent protein kinase l/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells Cancer Res 64 2004 1444 1451
88. F.A. Sinicrope Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer Mol Carcinog 45 2006 447 454
89. C.E. Clay, G.I. Atsumi, K.P. High, and F.H. Chilton Early de novo gene expression is required for 15-deoxy-Delta 12, 14-prostaglandin J2-induced apoptosis in breast cancer cells J Biol Chem 276 2001 47131 47135
90. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs J Biol Chem 272 1997 3406 3410